Date | Name | Activity | Value |
---|---|---|---|
Jan 30, 2024 | Glaxosmithkline Plc >10% Owner | Bought | $16500000 |
Dec 13, 2023 | Ra Capital Management, Llc Director, >10% Owner | Bought | $5000000 |
Date | Firm | Activity | Value |
---|---|---|---|
Mar 31, 2024 | Bought | $211007 | |
Mar 31, 2024 | Sold | $3453941 | |
Mar 31, 2024 | Sold | $3702956 | |
Mar 31, 2024 | Sold | $5851899 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
18,202,009 | Institution | 14.86% | 113,944,576 | |
7,688,079 | Institution | 6.28% | 48,127,375 | |
3,466,694 | Institution | 2.83% | 21,701,504 | |
3,317,970 | Institution | 2.71% | 20,770,492 | |
2,876,440 | Institution | 2.35% | 18,006,514 | |
1,706,059 | Institution | 1.39% | 10,679,929 | |
1,131,311 | Institution | 0.92% | 7,082,007 | |
972,693 | Institution | 0.79% | 6,089,058 | |
948,444 | Institution | 0.77% | 5,937,259 | |
691,834 | Institution | 0.56% | 4,330,881 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
3,317,970 | Institution | 2.71% | 20,770,492 | |
1,131,311 | Institution | 0.92% | 7,082,007 | |
972,693 | Institution | 0.79% | 6,089,058 | |
691,834 | Institution | 0.56% | 4,330,881 | |
660,737 | Institution | 0.54% | 4,136,214 | |
259,236 | Institution | 0.21% | 1,622,817 | |
175,813 | Institution | 0.14% | 1,100,589 | |
169,693 | Institution | 0.14% | 1,062,278 | |
81,955 | Institution | 0.07% | 513,038 | |
51,548 | Institution | 0.04% | 322,690 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
1,741,486 | Institution | 1.42% | 10,901,702 | |
1,359,608 | Institution | 1.11% | 6,702,867 | |
664,568 | Institution | 0.54% | 4,160,196 | |
605,024 | Institution | 0.49% | 3,787,450 | |
274,495 | Institution | 0.22% | 1,353,260 | |
155,837 | Institution | 0.13% | 919,438 | |
108,424 | Institution | 0.09% | 668,976 | |
88,671 | Institution | 0.07% | 555,080 | |
62,248 | Institution | 0.05% | 367,263 | |
50,262 | Institution | 0.04% | 247,792 |